BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32452626)

  • 1. Overcoming Obstacles in Pathological Diagnosis of Pulmonary Nodules through Circulating Tumor Cell Enrichment.
    Yin W; Zhu J; Ma B; Jiang G; Zhu Y; He W; Yang Y; Zhang Z
    Small; 2020 Jun; 16(25):e2001695. PubMed ID: 32452626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
    Xu Y; Li Q; Lin Z; Lin Y
    Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
    Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
    J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
    Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
    J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate receptor-positive circulating tumor cells in the preoperative diagnosis of indeterminate pulmonary nodules.
    Li Z; Cai J; Zhao Y; Cai J; Zhao X
    J Clin Lab Anal; 2022 Oct; 36(10):e24654. PubMed ID: 36217263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness.
    Zhou Q; Geng Q; Wang L; Huang J; Liao M; Li Y; Ding Z; Yang S; Zhao H; Shen Q; Pan C; Lou J; Lu S; Chen C; Luo Q
    EBioMedicine; 2019 Mar; 41():236-243. PubMed ID: 30872130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules.
    Ma G; Yang D; Li Y; Li M; Li J; Fu J; Peng Z
    Thorac Cancer; 2022 Dec; 13(23):3393-3401. PubMed ID: 36284506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
    Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
    Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study.
    Wei ZJ; Zhou BC; Wang GX; Han WX; Li YX; Xu AM
    Int J Clin Oncol; 2024 Feb; 29(2):149-158. PubMed ID: 38112831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules.
    Manjunath Y; Suvilesh KN; Mitchem JB; Avella Patino DM; Kimchi ET; Staveley-O'Carroll KF; Pantel K; Yi H; Li G; Harris PK; Chaudhuri AA; Kaifi JT
    JCO Precis Oncol; 2022 Mar; 6():e2100378. PubMed ID: 35417204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.
    Ding C; Zhou X; Xu C; Chen J; Ju S; Chen T; Liang Z; Cui Z; Li C; Zhao J
    Thorac Cancer; 2018 Nov; 9(11):1413-1420. PubMed ID: 30178907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer.
    Manjunath Y; Upparahalli SV; Suvilesh KN; Avella DM; Kimchi ET; Staveley-O'Carroll KF; Li G; Kaifi JT
    Lung Cancer; 2019 Aug; 134():147-150. PubMed ID: 31319973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study.
    Yan S; Guo W; Liu Y; Li K; Wang W
    Int J Clin Oncol; 2022 Mar; 27(3):538-544. PubMed ID: 35043284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
    Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
    Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study].
    Lian H; Ding Z; Yuan D; Ma J; Qin J
    Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):813-820. PubMed ID: 27978866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Vein-First vs Artery-First Surgical Technique on Circulating Tumor Cells and Survival in Patients With Non-Small Cell Lung Cancer: A Randomized Clinical Trial and Registry-Based Propensity Score Matching Analysis.
    Wei S; Guo C; He J; Tan Q; Mei J; Yang Z; Liu C; Pu Q; Ma L; Yuan Y; Lin F; Zhu Y; Liao H; Wang W; Liu Z; Li Q; Jiang B; Li C; Xia L; Zhao K; Gan F; Cheng J; Wu Z; Wang Y; Lin Y; Kou Y; Che G; Chen L; Li J; Liu L
    JAMA Surg; 2019 Jul; 154(7):e190972. PubMed ID: 31042283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer.
    Moon SM; Kim JH; Kim SK; Kim S; Kwon HJ; Bae JS; Lee S; Lee HS; Choi MY; Jeon BH; Jeong BH; Lee K; Kim HK; Kim J; Um SW
    Anticancer Res; 2020 Jun; 40(6):3435-3444. PubMed ID: 32487642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of recombinant virus-specific detection for viable circulating tumor cells in lung cancer patients].
    Xiao Y; Liu S; Wang ZZ; Chen Y; Li J; Li F
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Feb; 42(2):101-105. PubMed ID: 30704181
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study.
    Liu J; Han M; Huang H
    Transl Cancer Res; 2019 Aug; 8(4):1242-1248. PubMed ID: 35116866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.
    Zheng J; Ye X; Liu Y; Zhao Y; He M; Xiao H
    BMC Cancer; 2020 Feb; 20(1):106. PubMed ID: 32041568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.